Sotrastaurin acetate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sotrastaurin acetate, covering 2017-04-05 to 2017-04-05. Get the full timeline:
Most recent: Clinical Trial Update: Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation [Phase 2]